Hosking & Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$5.73M Buy
86,105
+6,079
+8% +$401K 0.39% 71
2015
Q1
$5.16M Buy
80,026
+4,797
+6% +$300K 0.37% 70
2014
Q4
$4.44M Buy
+75,229
New +$4.24M 0.33% 75

Other funds holding BMY

Hosking & Co's BMY Position: Q2 2015 in Review

Hosking & Co increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q2 2015, buying an estimated $401K and bringing the position to 86,105 shares worth $5.73M. The position accounts for 0.39% of the portfolio, ranked #71.

Hosking & Co first reported a position in BMY in Q4 2014 and has held it in 3 quarters since. 1,446 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

  • Hosking & Co held 86,105 shares of Bristol-Myers Squibb worth $5.73M as of Q2 2015.
  • Hosking & Co bought 6,079 Bristol-Myers Squibb shares in Q2 2015, an estimated $401K.
  • Bristol-Myers Squibb made up 0.39% of Hosking & Co's portfolio in Q2 2015, its #71 holding.
  • Hosking & Co first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 3 quarters since.
  • 1,446 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Hosking & Co's 13F filing for Q2 2015, filed 13 Aug 2015.